Filing Details

Accession Number:
0001209191-18-017543
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-06 19:54:36
Reporting Period:
2018-03-02
Accepted Time:
2018-03-06 19:54:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1180262 Herbalife Ltd. HLF Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1713270 J Mark Schissel 800 W. Olympic Blvd., Suite 406
Los Angeles CA 90015
Evp, Ww Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-03-02 8,442 $30.44 11,524 No 4 M Direct
Common Stock Disposition 2018-03-02 2,713 $94.72 8,811 No 4 D Direct
Common Stock Disposition 2018-03-02 1,982 $94.72 6,829 No 4 F Direct
Common Stock Disposition 2018-03-06 3,747 $65.57 3,082 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 D Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Appreciation Rights Disposition 2018-03-02 8,442 $0.00 8,442 $30.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-03-02 2025-03-02 No 4 M Direct
Footnotes
  1. The reporting person received 3,747 shares of common stock upon the net exercise of the 8,442 SARs. The reporting person forfeited 2,713 shares of common stock underlying the SARs in payment of the exercise price and 1,982 shares of common stock underlying the SARs to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on March 2, 2018 of $94.72.
  2. This transaction was effected pursuant to a Rule 10b5-1 trading plan.